EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Potential Impact of SARS-CoV-2 Spike Protein on HIV-1 Reservoir in People Living with HIV

Maurizio Federico iD

Viruses · 2026

DOI: 10.3390/v18020154 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2026. Verfasst von Maurizio Federico. Beteiligte Einrichtung: National Center for Global Health, Istituto Superiore di Sanità, 00161 Rome, Italy. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, HIV-1, HIV Infections, SARS-CoV-2. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Italy, Ministry of Health, Rome, Italy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

People living with HIV-1 (PLWH) are part of the so-called “fragile” populations to which COVID-19 vaccines were/are strongly recommended. The fact that most widely used COVID-19 vaccines rely on the production of a biologically active SARS-CoV-2 Spike protein expressed by synthetic mRNA poses the relevant question of whether and how this vaccination influences the fate of the HIV-1 reservoir. This report presents a detailed analysis of the literature data on the effects of SARS-CoV-2 Spike and COVID-19 vaccines on HIV-1 latently infected cells. Despite being limited in number, the experimental evidences consistently indicate that vaccine mRNA and/or SARS-CoV-2 Spike can effectively reactivate latent HIV-1. This conclusion has been drawn after “in vitro”, “ex vivo”, and “in vivo” assays, and with virus-associated Spike, soluble Spike, or its intracellular expression, as well as with COVID-19 mRNA vaccines. On the other hand, real-world observations on vaccinated PLWH under antiretroviral therapy (ART) provided evidence of HIV-1 reactivation almost exclusively in PLWH with unsuppressed viremia, as measured in terms of size of the HIV-1 reservoir. Although several issues still need to be clarified through urgent additional investigations, these data suggest the possibility that the Spike protein and/or the vaccine mRNA molecules affect the HIV-1 latency in PLWH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusHIV-1HIV InfectionsSARS-CoV-2COVID-19 VaccinesCOVID-19HumansVirus LatencyVirus Activation

Stichwörter der Autor:innen

HIV-1 reservoirSARS-CoV-2 SpikemRNA COVID-19 vaccinespeople living with HIV

Substanzen

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19 Vaccines

Autor:innen und Institutionen

  • National Center for Global Health, Istituto Superiore di Sanità, 00161 Rome, Italy.

ORCID-Profile: Maurizio Federico

Förderung

  • Ministry of Health, Italy
  • Ministry of Health, Rome, Italy

Zitieren

APA

Federico, M. (2026). Potential Impact of SARS-CoV-2 Spike Protein on HIV-1 Reservoir in People Living with HIV. Viruses. https://doi.org/10.3390/v18020154

Vancouver

Federico M. Potential Impact of SARS-CoV-2 Spike Protein on HIV-1 Reservoir in People Living with HIV. Viruses. 2026. doi:10.3390/v18020154

BibTeX
@article{Federico2026,
  author = {Federico, Maurizio},
  title = {Potential Impact of SARS-CoV-2 Spike Protein on HIV-1 Reservoir in People Living with HIV},
  journal = {Viruses},
  year = {2026},
  doi = {10.3390/v18020154}
}
Kostenlos starten →